Found: 6
Select item for more details and to access through your institution.
Impact of the 13-Valent Conjugated Pneumococcal Vaccine on the Direct Costs of Invasive Pneumococcal Disease Requiring Hospital Admission in Children Aged < 5 Years: A Prospective Study.
- Published in:
- Vaccines, 2020, v. 8, n. 3, p. 387, doi. 10.3390/vaccines8030387
- By:
- Publication type:
- Article
Effect of COVID-19 Pandemic on Invasive Pneumococcal Disease in Children, Catalonia, Spain.
- Published in:
- Emerging Infectious Diseases, 2022, v. 28, n. 11, p. 2321, doi. 10.3201/eid2811.211741
- By:
- Publication type:
- Article
Failures of 13-Valent Conjugated Pneumococcal Vaccine in Age-Appropriately Vaccinated Children 2-59 Months of Age, Spain.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Complicated pneumococcal pneumonia with pleural effusion or empyema in the 13‐valent pneumococcal conjugate vaccine era.
- Published in:
- Pediatric Pulmonology, 2019, v. 54, n. 5, p. 517, doi. 10.1002/ppul.24279
- By:
- Publication type:
- Article
Three-year prevalence of self-harm behaviors among the reasons for emergency visits of children and adolescents.
- Published in:
- Actas Espanolas de Psiquiatria, 2021, v. 49, n. 1, p. 35
- By:
- Publication type:
- Article
Effectiveness of the 13-valent pneumococcal conjugate vaccine in preventing invasive pneumococcal disease in children aged 7-59 months. A matched case-control study.
- Published in:
- PLoS ONE, 2017, v. 12, n. 8, p. 1, doi. 10.1371/journal.pone.0183191
- By:
- Publication type:
- Article